Effects of blocking androgen receptor expression with specific hammerhead ribozyme on in vitro growth of prostate cancer cell line

Chinese Medical Journal

Volumn 116, Issue 10, 2003, Pages 1515-1518

  Tong, Qiangsong ^a   Zhao, Jun ^a   Chen, Zhaohui ^a   Zeng, Fuqing ^a   Lu, Gongcheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Androgen receptor; Gene expression; Prostate cancer; Ribozyme

Indexed keywords

ANDROGEN RECEPTOR; LIPOFECTAMINE; MESSENGER RNA; RIBOZYME; TETRAZOLIUM;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL ASSAY; CELL CYCLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL STRUCTURE; COLORIMETRY; CONTROLLED STUDY; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NICK END LABELING; PROSTATE CANCER; PROTEIN LOCALIZATION; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; CELL LINE, TUMOR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, CATALYTIC; TRANSFECTION;

EID: 0344034639     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-839.
2. Catalona WJ. Management of cancer of the prostate. N Engl J Med 1994;331:996-1004.
3. Tilley WD, Marcelli M, Wilson JD, et al. Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci U S A 1989;86:327-331.
4. Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 3 ed. New York: Cold Spring Harbor Laboratory Press; 1998:254-325.
5. Dawson NA. Treatment of progressive metastatic prostate cancer. Oncology 1993;7:17-24.
6. Visakorpi T, Hyytinen E, Koivisto P, et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995;9:401-406.
7. Lavrovsky Y, Chen S, Roy AK. Therapeutic potential and mechanism of action of oligonucleotides and ribozymes. Biochem Mol Med 1997;62:11-22.
8. Sarver N, Cantin EM, Chang PS, et al. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 1990;247: 1222-1225.
9. Juhl H, Downing SG, Wellstein A, et al. HER-2/neu is rate-limiting for ovarian cancer growth. Conditional depletion of HER-2/neu by ribozyme targeting. J Biol Chem 1997;272: 29482-29486.
10. Ole Matzura, Anders Wennborg. RNAdraw: an integrated program for RNA secondary structure calculation and analysis under 32-bit microsoft windows. Comput Appli Biosci 1996; 12: 247-249.